Project Grant 1819626

The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to Lumostech, Inc. under the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a smart sleep mask and mobile application to improve sleep for adolescents. The one-year project will apply light flash technology delivered through a sleep mask to advance teenagers' circadian phases without disrupting daytime activities. Cognitive behavioral therapy delivered via mobile...

This National Science Foundation Project Grant of $255,851 awarded on September 15, 2022 will support the development of a neuromodulation device to promote healthy sleep cycles through the completion of prototype engineering. The awardee, Neurolight Inc. of Suffern, New York, will utilize controlled light and sound stimuli delivered via an externally worn system to transpose normal brain wave patterns associated with desired sleep states into recipients suffering from sleep disorders. This aims...

This two-year, $200,000 project grant from the National Science Foundation's Computer and Information Science and Engineering program (CFDA 47.070) will support the development of interpretable deep learning methods and software for automated sleep phenotyping using multimodal health sensing data. Beth Israel Deaconess Medical Center will leverage polyssomnography data and novel radio frequency sensing techniques to build accurate deep learning models for classifying sleep stages and apnea...

The National Science Foundation (NSF) awarded a $305,000 STTR Phase I project grant to Sensvita Inc. under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The project aims to develop a non-invasive radio frequency sensing technology for home-based monitoring of heart and lung function. The proposed system uses advanced sensing methods to measure critical physiological parameters without the need for skin contact or maintenance, improving the convenience, scalability,...

This Project Grant, awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports a three-year research initiative focused on investigating the relationship between naturalistic light exposure and sleep regularity. Funded at $248,705 with an award date of February 2, 2026, and completion date of January 31, 2029, the research is being conducted at Emory University in Atlanta, Georgia. The project addresses a critical...

The National Institute on Aging (NIA) awarded Brigham & Women's Hospital Inc. a $2,576,936 Project Grant under the Aging Research federal grant program (CFDA 93.866) to characterize the variability in sleep spindle activity across a population and evaluate the use of sleep spindle dynamics as biomarkers for Alzheimer's disease, mild cognitive impairment, and trisomy 21. The 3-year project will develop statistical models and methods to analyze sleep spindle patterns and their relationship...

Grant Award Summary Vena Vitals Inc., a women-owned small business, received a $920,616 Project Grant award dated September 24, 2025, from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award supports development and validation of VeriSleep, a wearable device designed to provide continuous, non-invasive blood pressure (BP) monitoring during sleep through beat-to-beat sensing technology. The device quantifies...

Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $678,710 to Henry Ford Health + Michigan State University Health Sciences on June 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and validate a novel multi-sensor machine learning (ML) approach for precision sleep tracking in nightshift workers. The project, which extends through April 30, 2030, addresses a critical public health gap by creating ML algorithms...

This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to Makani Science Inc. will develop a continuous respiratory monitoring platform to accurately classify apnea of prematurity (AOP) in premature newborns. The $371,021 award will fund a two-phase effort to build a multimodal monitoring system and machine learning models to identify the major AOP types (central, obstructive, and mixed). The initial R61 phase will develop the...

Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Arizona a $172,085 Project Grant on August 1, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct translational research on light-based intervention strategies for improving sleep and circadian health in early childhood. The primary deliverable is a five-week feasibility and preliminary efficacy study involving children ages 5.0–6.9 years with parent-reported sleep onset...